Form4insider filings, from the source

SEC Form 4 · accession 0001209191-17-057318

AGIOS PHARMACEUTICALS, INC. · AGIO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Oct 16, 2017
Accepted (ET)
Oct 18, 2017 · 5:34 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001439222

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common stockF2Oct 16, 2017S1,000$71.09D84,394D
Common stockF2,F3Oct 16, 2017S1,000$71.09D84,434ISee footnote
Common stockF4Oct 17, 2017S1,000$71.10D83,394D
Common stockF4,F3Oct 17, 2017S1,000$71.10D83,434ISee footnote
Common stockF5holding———20,803ISee footnote
Common stockF6holding———20,803ISee footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses